Endovia Health Sciences, Inc.
EDVA· NYSE
EDVAEndovia Health Sciences, Inc.
Filed Mar 27, 2020 · 10-K · 87 days after period end · 0001753926-20-000051
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $296.80K | $155.70K | $280.52K |
| Net Income | -$4.16M | -$14.52K | -$101.89K | -$37.22K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 27, 2020 · 87 d after period end
